BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19012056)

  • 1. Invasive, paediatric, vaccine strains of Streptococcus pneumoniae: are there differences in clinical characteristics?
    Trollfors B; Berg S; Backhaus E; Andersson R; Bossen Konradsen H
    Scand J Infect Dis; 2009; 41(2):84-7. PubMed ID: 19012056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
    Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
    Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.
    Hausdorff WP; Bryant J; Paradiso PR; Siber GR
    Clin Infect Dis; 2000 Jan; 30(1):100-21. PubMed ID: 10619740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.
    Hausdorff WP; Bryant J; Kloek C; Paradiso PR; Siber GR
    Clin Infect Dis; 2000 Jan; 30(1):122-40. PubMed ID: 10619741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
    Greenberg D
    Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
    Feikin DR; Klugman KP
    Clin Infect Dis; 2002 Sep; 35(5):547-55. PubMed ID: 12173128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics.
    Berg S; Trollfors B; Persson E; Backhaus E; Larsson P; Ek E; Claesson BE; Jonsson L; Rådberg G; Johansson S; Ripa T; Kaltoft MS; Konradsen HB
    Scand J Infect Dis; 2006; 38(6-7):427-32. PubMed ID: 16798688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain.
    García-Suárez Mdel M; Villaverde R; Caldevilla AF; Méndez FJ; Vázquez F
    Jpn J Infect Dis; 2006 Oct; 59(5):299-05. PubMed ID: 17060695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
    Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.
    Onwubiko C; Swiatlo E; McDaniel LS
    J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.